| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Short Communications |

From the Departments of Urology*
and
Pathology,
University of Washington,
Seattle, Washington
A set of monoclonal antibodies raised against lymphocyte cell surface molecules, the cluster designation (CD) antigens, was used to distinguish the constituent cell types of the prostate. The luminal secretory epithelial, basal epithelial, fibromuscular stromal, nerve sheath, and endothelial cells express distinctive complements of cell surface molecules that were identified by immunohistochemistry using 152 commercially available antibodies. Many of the CD antibodies stained lymphocyte populations in the prostate. These lymphocyte populations were grouped into abundance classes of rare, moderate, and high. Some of these molecules are expressed by multiple cell types, both parenchymal and lymphoid; others are expressed by only one cell type. Distinctive patterns of CD expression, which are most similar to the expression pattern of prostate luminal cells, also characterize a small series of Gleason score 6 prostate cancers. The cell-type specificity of CD molecules increases the prospect of isolating specific cell populations, using such techniques as laser capture microdissection and flow cytometry, for cell-specific molecular studies.
Related articles in Am J Pathol:
This article has been cited by other articles:
![]() |
D. A. Lawson, L. Xin, R. U. Lukacs, D. Cheng, and O. N. Witte Isolation and functional characterization of murine prostate stem cells PNAS, January 2, 2007; 104(1): 181 - 186. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. Knudsen, J. M. Lucas, L. Fazli, S. Hawley, S. Falcon, I. M. Coleman, D. B. Martin, C. Xu, L. D. True, M. E. Gleave, et al. Regulation of Hepatocyte Activator Inhibitor-1 Expression by Androgen and Oncogenic Transformation in the Prostate Am. J. Pathol., July 1, 2005; 167(1): 255 - 266. [Abstract] [Full Text] [PDF] |
||||
![]() |
D M Peehl Primary cell cultures as models of prostate cancer development Endocr. Relat. Cancer, March 1, 2005; 12(1): 19 - 47. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Y. Liu, M. P. Roudier, and L. D. True Heterogeneity in Primary and Metastatic Prostate Cancer as Defined by Cell Surface CD Profile Am. J. Pathol., November 1, 2004; 165(5): 1543 - 1556. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Zieziulewicz, D. W. Unfricht, N. Hadjout, M. A. Lynes, and D. A. Lawrence Shrinking the Biologic World--Nanobiotechnologies for Toxicology Toxicol. Sci., August 1, 2003; 74(2): 235 - 244. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |